Abstract:Abstract Background It was demonstrated that multifunctional protein APE1 (Apurinic/apyrimidinic endonuclease 1) is closely related to tumor immune microenvironment in a number of investigations, Meanwhile, the abundance of tumor infiltrating lymphocytes (TILs) has been shown as a prognosis indicator in some researches. However, it remains unclear whether APE1 is involved in the process of TILs affecting the prognosis of patients. To this end, we investigated the associations between APE1 and TILs in non-small cell lung cancer (NSCLC) and explored whether APE1 would influence the associations of CD4 + T cells infiltration with the prognosis of patients. Methods Genome-wide expression datasets were obtained from the Gene Expression Omnibus (GEO) public database under accession number GSE68465, GSE30219, GSE31210 and GSE50081. MCPcounter and CIBERSORT analysis was conducted to evaluate the abundance of TILs in 1006 NSCLC patients of GEO database. Spearman correlation tests were used to evaluate correlations between abundance of various TILs and APE1 expression. RFS (recurrence free survival) was estimated using the Kaplan–Meier method and the Cox proportional-hazards model. The expression level of APE1 and tumor-infiltrating CD4 + T cells was evaluated by immunohistochemistry (IHC). Results The results showed that the abundance of CD4 + naïve T cells was negatively associated with the APE1 expression. CD4 + naïve T cells infiltration was a favorable prognostic factor for RFS, however, there was no effect of CD4 + T cells infiltration on RFS in patients with high APE1 expression. Subsequently, it was further confirmed that CD4 + T cells infiltration was negatively associated with the APE1 expression level in 108 NSCLC tissue samples; high CD4 + T cells infiltration was associated with longer RFS in low APE1 expression group but not in APE1 high expression group. Conclusion These results suggested that APE1 may affect the relationship between CD4 + T cells infiltration and prognosis in NSCLC. This study provides new insights into predictors of outcome in patients with NSCLC, and suggests that combining immunotherapy and APE1-targeted therapy may be a promising treatment for NSCLC.

[The Expression of APE1 Gene and Its Clinical Implication in Hepatocellular Carcinoma: A Study Using Tissue Chip Assay].

Pathological assessment of follicular loss in laparoscopic endometrioma excision: Effects of cyst size and surgeon's experience

Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma

Clinical Implication of Keap1 and Phosphorylated Nrf2 Expression in Hepatocellular Carcinoma.

Expression of APE1 in Breast Invasive Ductal Carcinoma and Its Relationship with Prognosis

Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis

Apobec3g Expression is Correlated with Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis

Mass spectrometry and HPLC with fluorescent detection-based orthogonal approaches to characterize N-linked oligosaccharides of recombinant monoclonal antibodies.

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

KEAP1 overexpression is correlated with poor prognosis and immune infiltration in liver hepatocellular carcinoma

Levothyroxine overdose associated with seizures in a young child.

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

ASF1B Serves As a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma

APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC

Overexpressed Pepsinogen C is Associated with Poor Prognosis in Human Hepatocellular Carcinoma: a Tissue Microarray Study

Research of APEH Gene Expression in Clear-Cell Renal Cell Carcinoma

Low APOA-1 Expression in Hepatocellular Carcinoma Patients Is Associated With DNA Methylation and Poor Overall Survival

Apolipoprotein A1: a Novel Serum Biomarker for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection

Deciphering the influence of AP1M2 in modulating hepatocellular carcinoma growth and Mobility through JNK/ErK signaling pathway control

Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus-related hepatocellular carcinoma